Bioxcel Therapeutics logo

Bioxcel Therapeutics share price today

(BTAI)

Bioxcel Therapeutics share price is $0.34 & ₹28.89 as on 21 Dec 2024, 2.30 'hrs' IST

$0.34

0.03

(8.12%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Bioxcel Therapeutics share price in Dollar and Rupees. Guide to invest in Bioxcel Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Bioxcel Therapeutics. Get details on the Indian mutual funds that are investing in Bioxcel Therapeutics. Get Analyst recommendations and forecasts along with all the Bioxcel Therapeutics's financials.

Bioxcel Therapeutics share price movements

  • Today's Low: $0.30
    Today's High: $0.34

    Day's Volatility :12.46%

  • 52 Weeks Low: $0.30
    52 Weeks High: $4.17

    52 Weeks Volatility :92.8%

Bioxcel Therapeutics Returns

PeriodBioxcel TherapeuticsSector (Health Care)Index (Russel 2000)
3 Months
-41.11%
-11.1%
0.0%
6 Months
-71.34%
-6.0%
0.0%
1 Year
-88.75%
2.7%
0.0%
3 Years
-98.44%
0.6%
-19.7%

Bioxcel Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.3154
Open
$0.302
Today's High
$0.3442
Today's Low
$0.3013
Market Capitalization
$15.2M
Today's Volume
$825.5K
52 Week High
$4.17
52 Week Low
$0.3001
Revenue TTM
$2.4M
EBITDA
$-104.3M
Earnings Per Share (EPS)
$-2.04
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1766.94%

How to invest in Bioxcel Therapeutics from India?

It is very easy for Indian residents to invest directly in Bioxcel Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bioxcel Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bioxcel Therapeutics or BTAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bioxcel Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bioxcel Therapeutics shares which would translate to 2.499 fractional shares of Bioxcel Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Bioxcel Therapeutics, in just a few clicks!

Returns in Bioxcel Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bioxcel Therapeutics investment value today

Current value as on today

₹1,90,975

Returns

₹90,975

(+90.97%)

Returns from Bioxcel Therapeutics Stock

₹88,779 (false-88.78%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Bioxcel Therapeutics

1075.0%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Investment in Bioxcel Therapeutics from India has grown in the last 30 days as on Dec 21, 2024. 1075.0% more purchase transactions for Bioxcel Therapeutics in the last 30 days versus the previous period.

204%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Bioxcel Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 204% more investors are searching Bioxcel Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Bioxcel Therapeutics

  • Vanguard Group Inc

    2.48%

  • BlackRock Inc

    0.91%

  • Geode Capital Management, LLC

    0.62%

  • Wells Fargo & Co

    0.38%

  • Renaissance Technologies Corp

    0.27%

  • Millennium Management LLC

    0.27%

Analyst Recommendation on Bioxcel Therapeutics

Buy

    69%Buy

    30%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Bioxcel Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
10
Hold
4
5
4
Sell
0
0
0

Analyst Forecast on Bioxcel Therapeutics

What analysts predicted

Upside of 1370.59%

Current:

$0.34

Target:

$5.00

Insights on Bioxcel Therapeutics

  • Price Movement

    In the last 7 days, BTAI stock has moved down by -17.3%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.10M → 214.0K (in $), with an average decrease of 80.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -8.29M → -13.65M (in $), with an average decrease of 64.5% per quarter
  • BTAI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 35.5% return, outperforming this stock by 124.0%
  • BTAI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 23.0% return, outperforming this stock by 121.4%
  • Price to Sales

    ForBTAI every $1 of sales, investors are willing to pay $4.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.9 for every $1 of sales.

Bioxcel Therapeutics Technicals Summary

Sell

Neutral

Buy

Bioxcel Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Bioxcel Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bioxcel Therapeutics
-40.24%
-71.34%
-88.75%
-98.44%
-96.5%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bioxcel Therapeutics
NA
NA
NA
-1.57
-17.67
-0.64
NA
-1.89
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bioxcel Therapeutics
Buy
$15.2M
-96.5%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

About Bioxcel Therapeutics

bioxcel therapeutics, inc. is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology. the company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. the company's two most advanced clinical development programs are bxcl501, a sublingual thin film formulation designed for acute treatment of agitation resulting from neurological and psychiatric disorders, and bxcl701, an immuno-oncology agent designed for treatment of a rare form of prostate cancer and for treatment of pancreatic cancer.
Organization
Bioxcel Therapeutics
Employees
74
CEO
Dr. Vimal D. Mehta Ph.D.
Industry
Health Technology

Management People of Bioxcel Therapeutics

NameTitle
Dr. Vimal D. Mehta Ph.D.
Founder, CEO, President, & Director
Mr. Richard I. Steinhart MBA
Senior VP & CFO
Dr. Frank D. Yocca Ph.D.
Senior VP & Chief Scientific Officer
Dr. Vincent J. O'Neill B.Sc., M.D., M.R.C.P.
Executive VP and Chief of Product Development & Medical Officer
Dr. Chetan D. Lathia Ph.D.
Senior VP and Head of Translational Medicine, Clinical Pharmacology & Regulatory Affairs
Dr. Robert Risinger M.D.
Chief Medical Officer - Neuroscience

Important FAQs about investing in Bioxcel Therapeutics from India :

What is Bioxcel Therapeutics share price today?

Bioxcel Therapeutics share price today stands at $0.34, Open: $0.30 ; Previous Close: $0.32 ; High: $0.34 ; Low: $0.30 ; 52 Week High: $4.17 ; 52 Week Low: $0.30. The stock opens at $0.30, after a previous close of $0.32. The stock reached a daily high of $0.34 and a low of $0.30, with a 52-week high of $4.17 and a 52-week low of $0.30.

Can Indians buy Bioxcel Therapeutics shares?

Yes, Indians can invest in the Bioxcel Therapeutics (BTAI) from India.

With INDmoney, you can buy Bioxcel Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bioxcel Therapeutics at zero transaction cost.

How can I buy Bioxcel Therapeutics shares from India?

It is very easy to buy Bioxcel Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bioxcel Therapeutics be purchased?

Yes, you can buy fractional shares of Bioxcel Therapeutics with INDmoney app.

What are the documents required to start investing in Bioxcel Therapeutics stocks?

To start investing in Bioxcel Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bioxcel Therapeutics

Today’s highest price of Bioxcel Therapeutics (BTAI) is $0.34.

Today’s lowest price of Bioxcel Therapeutics (BTAI) is $0.30.

What is today's market capitalisation of Bioxcel Therapeutics

Today's market capitalisation of Bioxcel Therapeutics BTAI is 15.2M

What is the 52 Week High and Low Range of Bioxcel Therapeutics

  • 52 Week High

    $4.17

  • 52 Week Low

    $0.30

What are the historical returns of Bioxcel Therapeutics?

  • 1 Month Returns

    -40.24%

  • 3 Months Returns

    -71.34%

  • 1 Year Returns

    -88.75%

  • 5 Years Returns

    -96.5%

Who is the Chief Executive Officer (CEO) of Bioxcel Therapeutics

Dr. Vimal D. Mehta Ph.D. is the current Chief Executive Officer (CEO) of Bioxcel Therapeutics.